Aubrey de Grey and Antagonistic Pleiotropy
A source in Aubrey de Grey's dossier cites growing evidence for antagonistic pleiotropy in mammalian aging, though whether de Grey authored or endorsed the claim is not clear from available data.
Antagonistic pleiotropy is the theory that selection can favor gene-expression programs that benefit organisms early in life even when those same programs later reduce regenerative capacity and contribute to age-related pathology. A source in Aubrey de Grey's dossier invokes this mechanism directly: "Growing evidence supports the antagonistic pleiotropy theory of mammalian aging."
The source points to a specific case: programs tied to the embryonic-fetal transition confer tumor-suppressive and antiviral benefits early in life but are later linked to fibrosis, degenerative disease, and loss of regeneration.
The available data does not show whether de Grey wrote this himself, cited someone else's work, or simply appeared in the context of a document containing the statement. How the theory fits into his own strategies for addressing aging is not established in the material we have.
The edge links a prominent longevity theorist to a mechanistically concrete evolutionary theory of aging. The textual association is clear, but its direction, de Grey as author, as discussant, or as incidental context, is genuinely unresolved and worth surfacing. The embryonic-fetal program mechanism (early tumor suppression and antiviral immunity trading against later regenerative capacity) is specific enough to explain without inflation, and the open question gives the reader a real reason to follow the source link.